Pharma

All articles by Pharma

Horizon Therapeutics is up for grabs; Sanofi and Amgen are ready to use cash for bids.
Horizon Therapeutics is up for grabs; Sanofi and Amgen are ready to use cash for bids.
Jack O'Brien
December 2, 2022
2:36 pm

Horizon benefits from an illustrious reputation in the industry, especially among patients.

Five things for pharma marketers to know: Friday, December 2, 2022
Five things for pharma marketers to know: Friday, December 2, 2022
Jack O'Brien
December 2, 2022
5:30 am

Elon Musk says Neuralink aims to implant chips in humans within six months; U.S. sees surge in respiratory viruses for children under five; Pfizer invests more than $1.2 billion in Ireland.

Alex Gorsky to step down as J&J chair in 2023
Alex Gorsky to step down as J&J chair in 2023
Jack O'Brien
December 1, 2022
9:44 am

Gorsky is set to depart from the pharma giant after a 30-year career.

Five things for pharma marketers to know: Thursday, December 1, 2022
Five things for pharma marketers to know: Thursday, December 1, 2022
Jack O'Brien
December 1, 2022
5:00 am

J&J sues Amgen over ulcerative colitis drug similar to Stelara; Researchers studying whether Paxlovid can treat long COVID; Horizon Therapeutics takeover interest fuels stock price.

Five things for pharma marketers to know: Wednesday, November 30, 2022
Five things for pharma marketers to know: Wednesday, November 30, 2022
Jack O'Brien
November 30, 2022
5:00 am

Guillain-Barré syndrome may have been sparked by RSV; Flu hospitalizations outpace COVID-19 hospitalizations; A common treatment for joint pain links to faster arthritis progression.

AstraZeneca expands oncology portfolio with $320M deal for Neogene Therapeutics
AstraZeneca expands oncology portfolio with $320M deal for Neogene Therapeutics
Jack O'Brien
November 29, 2022
10:49 am

The deal is slated to be closed during Q1 2023, subject to customary closing conditions and regulatory approvals.

Five things for pharma marketers to know: Tuesday, November 29, 2022
Five things for pharma marketers to know: Tuesday, November 29, 2022
Lecia Bushak
November 29, 2022
5:00 am

FDA grants Sarepta accelerated review for its Duchenne gene therapy drug; Axsome Therapeutics announces positive results for Alzheimer’s agitation therapy; AstraZeneca signs a $402 million licensing deal with C4X Discovery.

Sanofi moves into new headquarters in Paris
Sanofi moves into new headquarters in Paris
Jack O'Brien
November 28, 2022
11:02 am

The French pharma giant said that each employee’s carbon footprint has been reduced by about 100% compared to the previous site.

Pharma’s digital marketing in crosshairs, as FTC’s plan to curb ‘commercial surveillance’ gains steam
Pharma’s digital marketing in crosshairs, as FTC’s plan to curb ‘commercial surveillance’ gains steam
Marc Iskowitz
November 28, 2022
10:44 am

An FTC proposal to tamp down on surveillance marketing is getting a boost from Planned Parenthood and others seeking limits on the use of health data.

Five things for pharma marketers to know: Monday, November 28, 2022
Five things for pharma marketers to know: Monday, November 28, 2022
Jack O'Brien
November 28, 2022
5:00 am

WHO renames monkeypox as ‘MPOX’; How to make COVID-19 the last pandemic; Biotech stocks are set to shine in 2023.

  • From Our Partners